NCT00566371View on ClinicalTrials.gov

The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

June 30, 2009

Conditions
Attention Deficit Hyperactivity DisorderInsomnia
Interventions
DRUG

atomoxetine

Patients will then be randomized (at Visit 2) to receive either atomoxetine or placebo for 4 weeks (Treatment Period); study drug will be titrated individually according to tolerability and efficacy (measured by ADHD-RS and CGI-I) completed at Visits 3, 4, 5, and 6) at 7-10 day intervals to a maximum dose of 1.8 mg/kg.

DRUG

placebo

placebo

Trial Locations (1)

02903

Rhode Island Hospital, Providence

All Listed Sponsors
lead

Rhode Island Hospital

OTHER